Shares of COPT Defense Properties (NYSE:CDP – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight research firms that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $33.6250.
CDP has been the topic of several recent research reports. Jefferies Financial Group upped their price target on shares of COPT Defense Properties from $33.00 to $34.00 and gave the company a “buy” rating in a report on Tuesday, January 27th. Cantor Fitzgerald lifted their price objective on COPT Defense Properties from $33.00 to $37.00 and gave the stock an “overweight” rating in a research report on Monday, February 9th. Evercore reaffirmed an “outperform” rating on shares of COPT Defense Properties in a research note on Friday, February 6th. Truist Financial increased their target price on COPT Defense Properties from $30.00 to $31.00 and gave the company a “hold” rating in a report on Monday, December 15th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of COPT Defense Properties in a research report on Wednesday, January 21st.
COPT Defense Properties Stock Down 0.6%
COPT Defense Properties (NYSE:CDP – Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.02. COPT Defense Properties had a return on equity of 9.82% and a net margin of 19.94%.The business had revenue of $197.36 million during the quarter, compared to the consensus estimate of $188.79 million. During the same quarter in the previous year, the company posted $0.65 EPS. The business’s revenue was up 7.6% on a year-over-year basis. COPT Defense Properties has set its FY 2026 guidance at 2.710-2.790 EPS and its Q1 2026 guidance at 0.670-0.690 EPS. Analysts anticipate that COPT Defense Properties will post 2.67 EPS for the current fiscal year.
Institutional Investors Weigh In On COPT Defense Properties
Hedge funds have recently modified their holdings of the company. California State Teachers Retirement System raised its position in shares of COPT Defense Properties by 0.4% in the second quarter. California State Teachers Retirement System now owns 104,190 shares of the company’s stock valued at $2,874,000 after buying an additional 457 shares during the last quarter. Arizona State Retirement System raised its holdings in COPT Defense Properties by 1.4% in the 3rd quarter. Arizona State Retirement System now owns 33,402 shares of the company’s stock valued at $971,000 after acquiring an additional 459 shares during the last quarter. GAMMA Investing LLC raised its holdings in COPT Defense Properties by 31.2% in the 3rd quarter. GAMMA Investing LLC now owns 1,973 shares of the company’s stock valued at $57,000 after acquiring an additional 469 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of COPT Defense Properties by 2.5% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 20,780 shares of the company’s stock worth $588,000 after purchasing an additional 513 shares during the period. Finally, Arkadios Wealth Advisors boosted its holdings in shares of COPT Defense Properties by 4.5% during the third quarter. Arkadios Wealth Advisors now owns 12,672 shares of the company’s stock worth $368,000 after purchasing an additional 540 shares during the last quarter.
About COPT Defense Properties
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
Featured Stories
- Five stocks we like better than COPT Defense Properties
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
